Evopoint Biosciences Co., Ltd. (SHA:688837)

China · Delayed Price · Currency is CNY

49.40

+5.79 (13.28%)

Sep 30, 2026, 3:00 PM CST

Evopoint Biosciences Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	2.42	1.28	1.45	0.71	0.79
Debt / EBITDA Ratio	2.60	3.59	-	-	-
Debt / FCF Ratio	6.11	7.77	-	-	-
Net Debt / Equity Ratio	0.58	0.11	0.38	-0.20	-0.15
Net Debt / EBITDA Ratio	0.63	0.33	-0.31	0.27	0.13
Net Debt / FCF Ratio	1.47	0.69	-0.35	0.26	0.12
Asset Turnover	-	0.66	-	-	-
Quick Ratio	1.80	2.66	1.24	2.67	2.52
Current Ratio	2.00	2.95	1.37	2.78	2.61
Return on Equity (ROE)	-	38.13%	-82.26%	-82.22%	-
Return on Assets (ROA)	-	9.28%	-25.96%	-27.41%	-
Return on Invested Capital (ROIC)	42.65%	22.51%	-96.44%	-105.74%	-133.77%
Return on Capital Employed (ROCE)	32.00%	14.70%	-59.40%	-48.20%	-70.10%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Payout Ratio	6.62%	11.89%	-	-	-
Buyback Yield / Dilution	-8.25%	-0.18%	-7.65%	-4.82%	-